Enovix Corporation (NASDAQ:ENVX) Given Consensus Rating of “Moderate Buy” by Brokerages

Enovix Corporation (NASDAQ:ENVXGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have given a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $11.7727.

A number of research analysts recently issued reports on ENVX shares. William Blair downgraded shares of Enovix from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Craig Hallum set a $7.00 price target on shares of Enovix in a research note on Thursday, August 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a report on Wednesday, July 8th. Loop Capital upgraded shares of Enovix to a “strong-buy” rating in a report on Monday, August 17th. Finally, Bank of America reissued a “neutral” rating and set a $5.00 price objective on shares of Enovix in a research report on Monday, August 17th.

Read Our Latest Research Report on Enovix

Enovix Stock Performance

Shares of ENVX opened at $3.06 on Friday. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46. The stock has a market capitalization of $671.52 million, a P/E ratio of -3.78 and a beta of 2.31. The firm’s fifty day simple moving average is $3.79 and its two-hundred day simple moving average is $5.31. Enovix has a 12 month low of $2.85 and a 12 month high of $14.21.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The firm had revenue of $9.02 million during the quarter, compared to analyst estimates of $8.43 million. During the same period last year, the company posted ($0.13) EPS. The business’s quarterly revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, analysts predict that Enovix will post -0.8 EPS for the current year.

Institutional Investors Weigh In On Enovix

Several hedge funds and other institutional investors have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd acquired a new stake in Enovix in the 4th quarter valued at $30,000. Calamos Advisors LLC acquired a new position in shares of Enovix during the first quarter valued at about $60,000. Sequoia Financial Advisors LLC acquired a new position in shares of Enovix during the second quarter valued at about $61,000. Gateway Wealth Partners LLC bought a new stake in shares of Enovix during the first quarter worth about $68,000. Finally, Wealthfront Advisers LLC raised its holdings in shares of Enovix by 27.8% in the 1st quarter. Wealthfront Advisers LLC now owns 13,800 shares of the company’s stock worth $71,000 after acquiring an additional 3,001 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) is a battery technology company developing lithium-ion batteries with silicon-anode materials and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while maintaining safety and durability for applications that require compact, high-performance energy storage.

The company’s battery platform incorporates a silicon anode, a stainless-steel constraint system and its BrakeFlow technology, which is designed to help prevent thermal runaway from spreading within a battery pack.

See Also

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.